Andrew P. Mazar

Also affiliated with Fate Therapeutics (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1–143)”.

Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1–143)

Acta Crystallographica Section D Biological Crystallography(2005)10.1107/s0907444905014174

N/A

0.470DataRank · unranked

22 citations

Andrew P. Mazar, Graham Parry, Abd Al-Roof Higazi, Alice Kuo, Douglas B. Cines +1 more

Glycogen synthase kinase 3 activity enhances liver inflammation in MASH

JHEP Reports(2024)10.1016/j.jhepr.2024.101073

N/A

0DataRank · unranked

15 citations

Qianqian Guo, Kunimaro Furuta, Cristina Correia, Chady Meroueh, Hyun Se Kim Lee +15 more